AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $15,000 | +50.0% | 324 | +4.5% | 0.00% | – |
| Q3 2019 | $10,000 | -33.3% | 310 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | -34.8% | 310 | -7.2% | 0.00% | – |
| Q1 2019 | $23,000 | +53.3% | 334 | +2.8% | 0.00% | – |
| Q4 2018 | $15,000 | +1400.0% | 325 | +3150.0% | 0.00% | – |
| Q3 2018 | $1,000 | -88.9% | 10 | -93.3% | 0.00% | – |
| Q1 2017 | $9,000 | +80.0% | 150 | +18.1% | 0.00% | – |
| Q2 2016 | $5,000 | -54.5% | 127 | -53.3% | 0.00% | – |
| Q1 2016 | $11,000 | -15.4% | 272 | +34.7% | 0.00% | – |
| Q4 2015 | $13,000 | -7.1% | 202 | -1.5% | 0.00% | – |
| Q3 2015 | $14,000 | -39.1% | 205 | -2.8% | 0.00% | – |
| Q2 2015 | $23,000 | +15.0% | 211 | 0.0% | 0.00% | – |
| Q1 2015 | $20,000 | +150.0% | 211 | +197.2% | 0.00% | – |
| Q4 2014 | $8,000 | +100.0% | 71 | 0.0% | 0.00% | – |
| Q3 2014 | $4,000 | +33.3% | 71 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | – | 71 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $80,873,000 | 75.24% |
| Casdin Capital, LLC | 187,500 | $7,855,000 | 7.82% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 40,000 | $1,676,000 | 4.87% |
| BB BIOTECH AG | 2,363,321 | $99,011,000 | 3.91% |
| AlpInvest Partners B.V. | 30,000 | $1,257,000 | 2.49% |
| Opaleye Management Inc. | 85,000 | $3,561,000 | 2.38% |
| Opus Point Partners Management, LLC | 43,295 | $1,814,000 | 1.75% |
| Clarius Group, LLC | 47,666 | $1,997,000 | 1.06% |
| CAPITAL INTERNATIONAL LTD /CA/ | 260,600 | $10,918,000 | 0.79% |
| Eventide Asset Management | 300,800 | $12,602,000 | 0.77% |